Fenylepsin
Brand names,
Fenylepsin
Analogs
Fenylepsin
Brand Names Mixture
- Dilantin W Phenobarbital 15mg (Phenobarbital + Phenytoin Sodium)
- Dilantin W Phenobarbital 30mg Cap (Phenobarbital + Phenytoin Sodium)
Fenylepsin
Chemical_Formula
C15H12N2O2
Fenylepsin
RX_link
http://www.rxlist.com/cgi/generic/phenyt.htm
Fenylepsin
fda sheet
Fenylepsin
msds (material safety sheet)
Fenylepsin
Synthesis Reference
Henze, U.S. Pat. 2,409,754 (1946)
Fenylepsin
Molecular Weight
252.268 g/mol
Fenylepsin
Melting Point
286 oC
Fenylepsin
H2O Solubility
32 mg/L
Fenylepsin
State
Solid
Fenylepsin
LogP
2.241
Fenylepsin
Dosage Forms
Capsule (extended release); Liquid; Solution; Suspension; Tablet
Fenylepsin
Indication
For the control of generalized tonic-clonic (grand mal) and complex partial (psychomotor, temporal lobe) seizures and prevention and treatment of seizures occurring during or following neurosurgery.
Fenylepsin
Pharmacology
Phenytoin is an antiepileptic drug which can be useful in the treatment of epilepsy. The primary site of action appears to be the motor cortex where spread of seizure activity is inhibited. Phenytoin reduces the maximal activity of brain stem centers responsible for the tonic phase of tonic-clonic (grand mal) seizures. Phenytoin acts to damp the unwanted, runaway brain activity seen in seizure by reducing electrical conductance among brain cells. It lacks the sedation effects associated with phenobarbital. There are some indications that phenytoin has other effects, including anxiety control and mood stabilization, although it has never been approved for those purposes by the FDA.
Fenylepsin
Absorption
Bioavailability 70-100% oral, 24.4% for rectal and intravenous administration. Rapid rate of absorption with peak blood concentration expected in 1½ to 3 hours.
Fenylepsin
side effects and Toxicity
Oral, mouse: LD50 = 150 mg/kg; Oral, rat: LD50 = 1635 mg/kg. Symptoms of overdose include coma, difficulty in pronouncing words correctly, involuntary eye movement, lack of muscle coordination, low blood pressure, nausea, sluggishness, slurred speech, tremors, and vomiting.
Fenylepsin
Patient Information
Patients taking phenytoin should be advised of the importance of adhering strictly to the prescribed dosage
regimen, and of informing the physician of any clinical condition in which it is not possible to take the drug orally
as prescribed, eg, surgery, etc.
Patients should also be cautioned on the use of other drugs or alcoholic beverages without first seeking the
physician's advice.
Patients should be instructed to call their physician if skin rash develops.
The importance of good dental hygiene should be stressed in order to minimize the development of gingival
hyperplasia and its complications.
Do not use capsules which are discolored.
Fenylepsin
Organisms Affected
Humans and other mammals